)
)
Regencell Bioscience Holdings Limited Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Regencell Bioscience Holdings Limited
Access all reports
Regencell Bioscience Holdings Limited is a biotechnology company focused on developing traditional Chinese medicine-based treatments for neurocognitive disorders and degenerative conditions. The company’s research aims to address conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), utilizing natural and holistic treatment approaches. Regencell's therapies are grounded in traditional medical practices, combined with modern scientific methods, to offer alternative treatment options for patients with these neurological conditions. The company is headquartered in Hong Kong, and its shares are listed on the Nasdaq.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
RGC
Country
🇺🇸 United States